Exemestane is a Oral Tablet in the Human Prescription Drug category. It is labeled and distributed by Cadila Healthcare Limited. The primary component is Exemestane.
| Product ID | 70771-1374_2301b37f-ea7b-4462-9a2d-196a2e2b042a |
| NDC | 70771-1374 |
| Product Type | Human Prescription Drug |
| Proprietary Name | Exemestane |
| Generic Name | Exemestane |
| Dosage Form | Tablet |
| Route of Administration | ORAL |
| Marketing Start Date | 2018-10-08 |
| Marketing Category | ANDA / ANDA |
| Application Number | ANDA202602 |
| Labeler Name | Cadila Healthcare Limited |
| Substance Name | EXEMESTANE |
| Active Ingredient Strength | 25 mg/1 |
| Pharm Classes | Aromatase Inhibitor [EPC],Aromatase Inhibitors [MoA] |
| NDC Exclude Flag | N |
| Listing Certified Through | 2020-12-31 |
| Marketing Start Date | 2018-10-08 |
| NDC Exclude Flag | N |
| Sample Package? | N |
| Marketing Category | ANDA |
| Application Number | ANDA202602 |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Marketing Start Date | 2018-10-08 |
| Ingredient | Strength |
|---|---|
| EXEMESTANE | 25 mg/1 |
| SPL SET ID: | fab5468a-d5b7-45e3-b8b2-ed902fddd3a6 |
| Manufacturer | |
| UNII | |
| RxNorm Concept Unique ID - RxCUI | |
| UPC Code |
| NDC | Brand Name | Generic Name |
|---|---|---|
| 0054-0080 | Exemestane | Exemestane |
| 0378-5001 | Exemestane | exemestane |
| 0832-0595 | Exemestane | Exemestane |
| 44278-025 | Exemestane | EXEMESTANE |
| 47781-108 | Exemestane | Exemestane |
| 50090-5193 | Exemestane | Exemestane |
| 51991-005 | Exemestane | Exemestane |
| 59651-516 | Exemestane | Exemestane |
| 59762-2858 | EXEMESTANE | Exemestane |
| 63629-2056 | Exemestane | Exemestane |
| 65162-240 | Exemestane | Exemestane |
| 68382-383 | Exemestane | Exemestane |
| 69097-316 | EXEMESTANE | exemestane |
| 70771-1374 | Exemestane | Exemestane |
| 71921-190 | Exemestane | Exemestane |
| 0009-7663 | Aromasin | exemestane |